Latham Group Becomes Official Sponsor of USA Artistic Swimming
Latham Group signed on as an official sponsor of USA Artistic Swimming, the national governing body for the Olympic sport of artistic swimming in the United States. Brought together by a shared commitment to excellence, premium performance and a love of swimming, the partnership aims to inspire families to explore the enjoyment and confidence that grow from time spent in the water.
Trade with 70% Backtested Accuracy
Analyst Views on SWIM
About SWIM
About the author
Latham Appoints Sean Gadd as New CEO Effective January 5, 2026
- Leadership Transition: Latham Group has appointed Sean Gadd as the new CEO, succeeding Scott Rajeski, who has served for over eight years, with Gadd set to officially take over on January 5, 2026, which is expected to drive further development in the North American market.
- Extensive Industry Experience: Gadd brings 21 years of experience from James Hardie, where he held full P&L responsibility as President of North America, successfully driving organic net sales growth, which is anticipated to provide similar growth momentum for Latham.
- Strategic Transformation Opportunity: Gadd's appointment aligns with Latham's material conversion and market penetration strategies, expected to accelerate market share growth, particularly in the Sand States.
- Board Restructuring: Gadd will also join Latham's Board of Directors, replacing Rajeski, who is thanked for his contributions, emphasizing continuity and stability in leadership.
"Putting It All Together: FDIS May Have a Value of $115"
ETF Analysis: The Fidelity MSCI Consumer Discretionary Index ETF (FDIS) has an implied analyst target price of $114.84, indicating a potential upside of 12.38% from its current trading price of $102.19.
Notable Holdings: Key underlying holdings with significant upside potential include Latham Group Inc (SWIM), Planet Fitness Inc (PLNT), and Revolve Group Inc (RVLV), with expected price increases of 18.34%, 15.39%, and 15.02% respectively.
Market Sentiment: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they do not align with recent market developments.
Investor Research: It emphasizes the need for further investor research to assess the validity of analysts' targets in light of current company and industry trends.
